Healthcare -
Biotechnology - NASDAQ - US
$ 12.75
-1.01 %
$ 81 M
Market Cap
-1.85
P/E
Price Target
Average
178.43%
Revenue Forecast
Estimate
246.89%
EBIT
Estimate
--37.78%
Net Income
Estimate
15.71%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Assembly Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for ASMB of $35.5 , with forecasts ranging from
a
low of
$35 to a high of $36 .
ASMB Lowest Price Target
Wall Street Target
35 USD
174.51%
ASMB Average Price Target
Wall Street Target
35.5 USD
178.43%
ASMB Highest Price Target
Wall Street Target
36 USD
182.35%
REVENUE FORECAST
Revenue Forecast Chart ASMB
EBIT FORECAST
EBIT Forecast Chart ASMB
NET INCOME FORECAST
Net Income Chart ASMB